210 related articles for article (PubMed ID: 21354054)
1. Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.
Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
J Mol Diagn; 2011 Mar; 13(2):189-98. PubMed ID: 21354054
[TBL] [Abstract][Full Text] [Related]
2. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
[TBL] [Abstract][Full Text] [Related]
3. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.
Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
PLoS One; 2012; 7(11):e49249. PubMed ID: 23166620
[TBL] [Abstract][Full Text] [Related]
4. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
5. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
[TBL] [Abstract][Full Text] [Related]
7. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
[TBL] [Abstract][Full Text] [Related]
8. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
9. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
[TBL] [Abstract][Full Text] [Related]
10. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
11. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.
Gongoll S; Peters G; Mengel M; Piso P; Klempnauer J; Kreipe H; von Wasielewski R
Gastroenterology; 2002 Nov; 123(5):1478-84. PubMed ID: 12404222
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
[TBL] [Abstract][Full Text] [Related]
15. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
[TBL] [Abstract][Full Text] [Related]
16. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
[TBL] [Abstract][Full Text] [Related]
18. S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.
Treese C; Hartl K; Pötzsch M; Dahlmann M; von Winterfeld M; Berg E; Hummel M; Timm L; Rau B; Walther W; Daum S; Kobelt D; Stein U
Cells; 2022 Mar; 11(6):. PubMed ID: 35326507
[TBL] [Abstract][Full Text] [Related]
19. RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector.
Chen D; Zhang R; Shen W; Fu H; Liu S; Sun K; Sun X
Int J Oncol; 2013 May; 42(5):1763-9. PubMed ID: 23546393
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
